Company E&A Pharma Grup S.r.l. with Fiscal Code 16023
recorded a turnover of 2024 of
123.540,
with a net profit of
20.356
and having an average number of employees of
1.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
E&A Pharma Grup S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
122.305
78.807
69.246
91.484
82.945
68.632
81.181
89.129
101.469
123.540
Total Income - EUR
122.447
138.013
69.246
91.484
83.220
68.637
81.801
89.134
101.484
123.590
Total Expenses - EUR
128.314
132.320
93.220
82.083
57.332
70.096
98.914
75.350
83.364
101.121
Gross Profit/Loss - EUR
-5.867
5.693
-23.974
9.402
25.888
-1.459
-17.113
13.784
18.120
22.469
Net Profit/Loss - EUR
-6.648
4.369
-24.304
8.487
25.059
-2.742
-17.931
12.892
17.296
20.356
Employees
0
2
3
3
2
2
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 22.4%, from 101.469 euro in the year 2023, to 123.540 euro in 2024.
The Net Profit increased by 3.157 euro, from 17.296 euro in 2023, to 20.356 in the last year.
Check the financial reports for the company - E&A Pharma Grup S.r.l.
Financial Rating - E&A PHARMA GRUP S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - E&A Pharma Grup S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - E&A Pharma Grup S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - E&A Pharma Grup S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
E&A Pharma Grup S.r.l. - CUI 16023
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
10.719
0
0
0
0
37.910
25.080
15.122
6.009
1.057
Current Assets
40.703
45.971
28.949
41.271
45.181
30.877
24.909
32.097
52.797
72.610
Inventories
23.654
5.350
0
0
3.930
2.898
-339
1.274
10.987
2.209
Receivables
8.416
2.037
25.016
37.609
40.116
27.414
24.401
30.110
40.763
66.325
Cash
8.634
38.584
3.933
3.662
1.135
566
847
713
1.047
4.077
Shareholders Funds
30.350
28.051
6.911
15.271
40.034
36.533
17.792
30.739
47.942
68.030
Social Capital
112
111
109
107
105
103
101
101
101
101
Debts
21.072
17.920
22.038
26.000
5.147
32.254
32.197
16.479
10.864
5.637
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
72.610 euro in 2024 which includes Inventories of
2.209 euro, Receivables of
66.325 euro and cash availability of
4.077 euro.
The company's Equity was valued at
68.030 euro, while total Liabilities amounted to
5.637 euro.
Equity increased by 20.356 euro, from 47.942 euro in 2023, to 68.030 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - E&A Pharma Grup S.r.l.